KorrekturRandomisierte kontrollierte StudieOpen Access
Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”
Helicobacter · 2026-05 · 31 (3)
DOI: 10.1111/hel.70141 ↗Kurz gefasst
Korrektur in der Zeitschrift Helicobacter, online erschienen am 16.05.2026. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”. Helicobacter, 31(3). https://doi.org/10.1111/hel.70141
Vancouver
Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”. Helicobacter. 2026;31(3). doi:10.1111/hel.70141
BibTeX
@article{euvimed2026,
title = {Correction to “Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial”},
journal = {Helicobacter},
year = {2026},
volume = {31},
number = {3},
doi = {10.1111/hel.70141}
}
EUVIMED